Life Sciences Capital Fund Lp Burrill serves as Executive at Pharmasset Inc, where they oversee executive responsibilities. Since joining the company, Life Sciences Capital Fund Lp Burrill has executed 10 insider transactions totaling $2.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 7, 2011 involved purchasing 5,000 shares valued at $2.0K.
Life Sciences Capital Fund Lp Burrill currently holds 5,518,974 shares of Pharmasset Inc (VRUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Life Sciences Capital Fund Lp Burrill has been a net buyer of VRUS stock. They have purchased $2.1M and sold $0 worth of shares.
Life Sciences Capital Fund Lp Burrill's most recent insider trade was on Feb 7, 2011, when they purchased 5,000 shares at $0.40 per share.
Get notified when new Form 4 filings are submitted
| $0.40 |
| Discretionary |
| Feb 2, 2011 | DDXS | $6.0K | Purchase | 15,000 | $0.40 | Discretionary |
| Feb 1, 2011 | DDXS | $6.0K | Purchase | 15,300 | $0.39 | Discretionary |
| Jan 28, 2011 | DDXS | $4.9K | Purchase | 13,000 | $0.38 | Discretionary |
| Jan 24, 2011 | DDXS | $40.0K | Purchase | 100,000 | $0.40 | Discretionary |
| Jan 21, 2011 | DDXS | $22.2K | Purchase | 55,500 | $0.40 | Discretionary |
| May 2, 2007 | VRUS | $31.8K | Exercise | 212,099 | $0.15 | Discretionary |
| May 2, 2007 | VRUS | $2.0M | Purchase | 222,222 | $9.00 | Discretionary |
| May 2, 2007 | VRUS | $0 | Conversion | 388,250 | $N/A | Discretionary |